MichaelCharlesLoweMDMA

PubMed

• Impact of immunotherapy time-of-day infusion on survival and immunologic correlates in patients with metastatic renal cell carcinoma: a multicenter cohort analysis.
  Jimmy S Patel, Yena Woo, Amber Draper, Caroline S Jansen, Pasquale F Innominato, Francis A Lévi, Layla Dhabaan, Haydn Kissick, Jennifer W Carlisle, Viraj A Master, Meh...> ;Journal for Immunotherapy of Cancer. 2024 Mar 26
• Radiation and anti-PD-L1 synergize by stimulating a stem-like T cell population in the tumor-draining lymph node.
  Yang Shen, Erin Connolly, Meili Aiello, Chengjing Zhou, Prasanthi Chappa, Haorui Song, Patan Tippitak, Tarralyn Clark, Maria Cardenas, Nataliya Prokhnevska, Annapaola ...> ;Research Square. 2024 Mar 6
• 1 citations
  FcγRIIB expressed on CD8T cells limits responsiveness to PD-1 checkpoint inhibition in cancer.
  Kelsey B Bennion, Marvi Tariq, Megan M Wyatt, Charlotte Duneton, Kirsten M Baecher, Chrystal M Paulos, Ragini R Kudchadkar, Michael C Lowe, Mandy L Ford> ;Science Translational Medicine. 2023 Aug 23
• 2 citations
  Metastasectomy in Stage IV Melanoma: How and When Should We Employ It?
  Mark B Faries, Michael Lowe> ;Annals of Surgical Oncology. 2023 Sep 1
• 7 citations
  The Association of Improved Overall Survival with NSAIDs in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
  Nikhil T Sebastian, William A Stokes, Madhusmita Behera, Renjian Jiang, David A Gutman, Zhonglu Huang, Abigail Burns, Vidula Sukhatme, Michael C Lowe, Suresh S Ramalin...> ;Clinical Lung Cancer. 2023 May 1
• An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.
  Shannon, A., Straker, R., Carr, M., Sun, J., Landa, K., Baecher, K., Lynch, K., Bartels, H., Panchaud, R., Keele, L., Lowe, M., Slingluff, C., Jameson, M., Tsai, K., F...> ;Annals of Surgical Oncology. 2022 Oct 1
• ASO Visual Abstract: An Internally Validated Prognostic Risk Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.
  Shannon, A., Straker, R., Carr, M., Sun, J., Landa, K., Baecher, K., Lynch, K., Bartels, H., Panchaud, R., Keele, L., Lowe, M., Slingluff, C., Jameson, M., Tsai, K., F...> ;Annals of Surgical Oncology. 2022 Oct 1
• 1 citations
  Regional control after precision lymph node dissection for clinically evident melanoma metastasis.
  Kevin T Lynch, Yinin Hu, Norma E Farrow, Yun Song, Max O Meneveau, Minyoung Kwak, Michael C Lowe, Edmund K Bartlett, Georgia M Beasley, Giorgos C Karakousis, Craig L S...> ;Journal of Surgical Oncology. 2023 Jan 1
• 5 citations
  Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicent...
  James W Jakub, Michael Lowe, J Harrison Howard, Jeffrey M Farma, Amod Sarnaik, Todd Tuttle, Heather B Neuman, Charlotte E Ariyan, Abhineet Uppal, Steve Trocha, Georgia...> ;Annals of Surgical Oncology. 2022 Sep 1
• 5 citations
  Outcomes with adjuvant anti-PD-1 therapy in patients with sentinel lymph node-positive melanoma without completion lymph node dissection.
  Eroglu, Z., Broman, K., Thompson, J., Nijhuis, A., Hieken, T., Kottschade, L., Farma, J., Hotz, M., Deneve, J., Fleming, M., Bartlett, E., Sharma, A., Dossett, L., Hug...> ;Journal for Immunotherapy of Cancer. 2022 Aug 1
• 20 citations
  Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
  van Akkooi, A., Hieken, T., Burton, E., Ariyan, C., Ascierto, P., Asero, S., Blank, C., Block, M., Boland, G., Caraco, C., Chng, S., Davidson, B., Duprat Neto, J., Far...> ;Annals of Surgical Oncology. 2022 Jun 1
• 4 citations
  Impact of concomitant fibrates on immunotherapy outcomes for advanced non-small cell lung cancer.
  William A Stokes, Madhusmita Behera, Renjian Jiang, David A Gutman, Zhonglu Huang, Abigail Burns, Nikhil T Sebastian, Vidula Sukhatme, Michael C Lowe, Suresh S Ramalin...> ;Cancer Medicine. 2023 Jan 1
• Patterns of recurrence and prognosis in pathologic stage I and II Merkel cell carcinoma: A multicenter, retrospective cohort analysis.
  Andrew D Tieniber, Adrienne B Shannon, Michael J Carr, James Sun, Karenia Landa, Kirsten M Baecher, Kevin Lynch, Harrison G Bartels, Robyn Panchaud, Michael C Lowe, Cr...> ;Journal of the American Academy of Dermatology. 2023 Jan 1
• 1 citations
  ASO Visual Abstract: Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in...
  James W Jakub, Michael Lowe, J Harrison Howard, Jeffrey M Farma, Amod Sarnaik, Todd Tuttle, Heather B Neuman, Charlotte E Ariyan, Abhineet Uppal, Steve Trocha, Georgia...> ;Annals of surgical oncology. 2022 May 12
• 1 citations
  A Phase III, Multicenter, Randomized Controlled Trial Investigating 1-cm Versus 2-cm Surgical Excision Margins for Stage II Primary Cutaneous Melanoma (MelMarT-II).
  Alexander J Rossi, Mark B Faries, Marc Moncrieff, Michael Henderson, Jonathan M Hernandez, Michael C Lowe, Verbus, E.> ;Annals of Surgical Oncology. 2022 Apr 22
• 6 citations
  International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Majo...
  Kristy K Broman, Tasha M Hughes, Brooke C Bredbeck, James Sun, Dennis Kirichenko, Michael J Carr, Avinash Sharma, Edmund K Bartlett, Amanda A G Nijhuis, John F Thompso...> ;Annals of Surgery. 2023 May 1
• 1 citations
  ASO Visual Abstract: Talimogene Laherparepvec (T-VEC) for Treatment of Advanced Locoregional Melanoma after Failure of Immunotherapy: An International Multi-institutio...
  Michael J Carr, James Sun, Danielle DePalo, Luke D. Rothermel, Yun Song, Richard J. Straker, Kristin Baecher, Raphael J. Louie, Emma H. A. Stahlie, G. Paul Wright, Sye...> ;Annals of Surgical Oncology. 2021 Nov 24
• 1 citations
  Do Oncologic Outcomes From Head and Neck Versus Truncal and Extremity Melanoma Differ? A Single-Institution Single-Subspecialty Experience.
  Kirsten M Baecher, Michael K. Turgeon, Caroline R Medin, Geetha Mahendran, Terrill M Flakes, Keith A. Delman, Michael C. Lowe> ;The American Surgeon. 2021 Nov 11
• 1 citations
  Ford Versus Ferrari: Novel Technologies in the Setting of a Reliable Standard.
  Keith A. Delman, Meredith C. Mason, Michael C. Lowe> ;Annals of Surgical Oncology. 2021 Nov 10
• 5 citations
  Acral Lentiginous Melanoma: A United States Multi-Center Substage Survival Analysis
  Avani M. Kolla, Gerardo A. Vitiello, Erica B. Friedman, James Sun, Aishwarya Potdar, Hala Daou, Norma E. Farrow, Clara R. Farley, John T. Vetto, Dale Han, Marvi Tariq,...> ;Cancer Control. 2021 Nov 9
• 13 citations
  Talimogene Laherparepvec (T-VEC) for the Treatment of Advanced Locoregional Melanoma After Failure of Immunotherapy: An International Multi-Institutional Experience
  Michael J Carr, James Sun, Danielle DePalo, Luke D. Rothermel, Yun Song, Richard J. Straker, Kristin Baecher, Raphael J. Louie, Emma H. A. Stahlie, G. Paul Wright, Sye...> ;Annals of Surgical Oncology. 2021 Oct 14
• In Search of a More Accurate Nodal Staging System for Melanoma: Should We Sacrifice Simplicity?
  Kirsten M Baecher, Keith A. Delman, Michael C. Lowe> ;JAMA Surgery. 2021 Nov 1
• 14 citations
  Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.
  Maria Pino, Susan Pereira Ribeiro, Amélie Pagliuzza, Khader Ghneim, Anum Khan, Emily S. Ryan, Justin L. Harper, Colin T. King, Sarah Welbourn, Luca Micci, Sol del Mar ...> ;Plos Pathogens. 2021 Aug 27
• Correction to: The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma
  Ann Y. Lee, Erica B. Friedman, James Sun, Aishwarya Potdar, Hala Daou, Norma E. Farrow, Clara R. Farley, John T. Vetto, Dale Han, Marvi Tariq, Richard L. Shapiro, Geor...> ;Annals of Surgical Oncology. 2021 Apr 23
• 7 citations
  Predictors of False Negative Sentinel Lymph Node Biopsy in Clinically Localized Merkel Cell Carcinoma
  , , , , , , , , , , , , , , , , , , , > ;Annals of Surgical Oncology. 2021 Apr 22
• Join now to see all

Lectures

• Pilot integrated biomarker study of VX15/2503 in combination with ipilimumab and/or nivolumab in patients with resectable metastatic melanoma. 
  2019 ASCO Annual Meeting - 6/1/2019